/PRNewswire/ The global genome editing market size is estimated to grow by USD 7.23 bn from 2024-2028, according to Technavio. The market is estimated to.
Biotech Roundtable: Who will bring the next CRISPR drug to market? (NASDAQ:CRSP) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Verve Therapeutics' latest update on the Heart-1 Phase 1b trial of VERVE-101. Explore VERVE-102's development and regulatory clearances for the Heart-2 clinical trial, offering hope for patients with cardiovascular conditions.
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 14,320,000 shares, an increase of 9.2% from the February 29th total of 13,110,000 shares. Based on an average daily volume of 1,420,000 shares, […]